Point-of-Care Opioid Testing MarketThe point-of-care opioid testing market is anticipated to reach a valuation of US$ 450.9 million by 2023. The market is anticipated to grow at a 4.9% CAGR over the course of the forecast period, reaching US$ 725.1 million by 2033. The growing opioid epidemic, growing public awarene.
Where a plaintiff has brought suit alleging breach of a merger agreement, the facts alleged plausibly suggest that the plaintiff shareholders may be entitled to relief on claims for breach of contract, violation of G.L.c. 93A, and breach of the implied covenant of good faith and fair dealing, but a remaining count for breach of